Updated Data Matrix Available
Market Value Market Volume Market Forecast Epidemiology Clinical Trials Patent Landscape Regulatory Approvals
✓ PDF Report delivery✓ Single / Multi-user / Corporate licenses✓ Free Table of Contents on request✓ Analyst support included

Cell Counting and Viability Analyzers Market by Product Type (Benchtop Analyzers, Automated High-Throughput Systems and Portable Handheld Analyzers), Technology (Electrical Impedance, Flow Cytometry, Image-Based Cytometry and Fluorescence-Based Detection), and End User (Hospitals and Diagnostic Laboratories, Pharmaceutical and Biotechnology Companies, Academic and Research Institutions, Blood Banks and Contract Research Organizations) and Forecast 2034

$3,000.00

Report Specifications

The cell counting and viability analyzers market includes laboratory instruments, associated software, and integrated workflows used to quantify cell concentration and evaluate cell health across research, industrial, and clinical applications. These analyzers apply electronic, optical, and imaging technologies to generate rapid, reproducible measurements of live, dead, and total cells in suspension. Accurate counting and viability determination underpin experimental reproducibility, bioprocess control, and the safety of cell-based medicines.

Report attention is directed at how laboratories standardize routine quantification of cell samples, replacing manual microscope-based estimates with instrument-driven precision and documented data integrity. Consistent cell quality assessment is operationally vital wherever biological products are developed, cellular samples are characterized, or diagnostic specimens are processed, because small measurement deviations can compromise downstream results. Growing reliance on automation and digital recordkeeping further embeds these instruments into everyday laboratory practice.

The global cell counting and viability analyzers market research report provides market size (USD million, 2024 to 2034), market share analysis, growth trends and forecast (CAGR%, 2026 to 2034).

The global cell counting and viability analyzers market is segmented by product type (benchtop analyzers, automated high-throughput systems and portable handheld analyzers), technology (electrical impedance, flow cytometry, image-based cytometry and fluorescence-based detection), and end user (hospitals and diagnostic laboratories, pharmaceutical and biotechnology companies, academic and research institutions, blood banks and contract research organizations), and geography.

The global cell counting and viability analyzers market research report is further segmented by geography into North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), Latin America (Brazil, Mexico, Rest of LA), and Rest of the World.

In addition, the global cell counting and viability analyzers market report provides detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis, and market profitability analysis by key products and regions or countries. The report also tracks the major competitors operating in the global market through company overview, financial snapshots, major products, technologies, services offered and recent developments.

Major players operating in the global cell counting and viability analyzers market and profiled in this report include Thermo Fisher Scientific Inc., Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., Merck KGaA, ChemoMetec A/S, Sysmex Corporation, Horiba, Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., DeNovix Inc., and Abbott Laboratories, Inc.

DATA INCLUDED: Cell Counting and Viability Analyzers Market Size, Cell Counting and Viability Analyzers Market Share, Cell Counting and Viability Analyzers Market Growth Rates, Cell Counting and Viability Analyzers Market Trends, and Cell Counting and Viability Analyzers Market Forecast to 2034

Market Data:

  • Base Year Estimation: 2025
  • Historical Data Range: 2024-2025
  • Forecast Period: 2026-2034
  • Market Representation: Revenue in $million and CAGR % from 2026 to 2034
  • Regional Scope: North America, Europe, Asia Pacific, Latin America, Rest of the World (Middle East & Africa)
  • Country Scope: U.S., Canada, U.K., Germany, France, Italy, Spain, Japan, China, India, South Korea, Brazil, Mexico, South Africa, South Korea, Saudi Arabia, UAE, and other countries.
  • Report Coverage: Revenue forecasts, company market share, competitive landscape analysis, growth factors, and market trends
  • Customization Scope (15% Free): Accommodation of specific or custom requirements beyond the current report scope.

Qualitative Analysis:

  • Industry Overview
  • Industry Trends
  • Market Driver, Restraints, and Opportunities
  • Market Size
  • Growth Trends
  • Market Profitability Analysis
  • Market Attractiveness Matrix
  • Competitive Landscape
    • Company Overview
    • Financial Performance
    • Product Portfolio
    • Strategic Insights
    • Recent Developments

Quantitative Analysis:

  • Market Size Projections: Comprehensive estimates and forecasts for all segments
  • Regional Market Analysis: Estimates and forecasts for key countries
  • Corporate Financial Performance: Analysis of company financials
  • Competitive Landscape: Market share analysis of leading companies

SKU: CD0064 Category:

For inquiries regarding discounts on single or bundled report purchases, please reach out to us.

  1. Introduction
  2. Executive Summary
    • Market Size Estimation ($million, 2024-2034)
    • Forecast Estimation ($million and CAGR%, 2026-2034)
  3. Research Methodology
  4. Market Landscape
    • Market Dynamics
      • Drivers
      • Barriers
      • Opportunities
    • Market Share Analysis
      • Companies
      • Products
    • Market Trends Analysis
      • Key success factors
      • Market Growth Rate
    • Market Attractiveness Analysis
    • Market Profitability Analysis
      • Buyer power
      • Supplier power
      • Barriers to entry
      • Threat of substitute products
      • Rivalry among firms in the industry
    • Distribution Channels
  5. Market Segmentation [refer Market Segments and Companies Tab]
    • Diagnostic Test Type
    • Indication or Infection Type
    • Technology
    • Diagnostics Application
    • Service Type
    • End User Groups
  6. Geography (Region, Country)
    • North America (U.S., Canada)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Rest of the World (Middle East & Africa)
  7. Regulatory Overview 
    • Device Classification I, II, III, IV
    • Device (FDA, EMEA) Approvals
  8. Company Profiles [refer Market Segments and Companies Tab]
    • Company Overview
    • Financial Snapshot
    • Product Portfolio
    • Business Strategies
    • Recent Developments
  9. Recommendations
  10. References

Key Questions Answered:
1. What are the factors driving and limiting this market, key success factors and challenges?
2. Which are the leading competitors in the market, their market share, profitability and key trends by product, technology, services portfolio?
3. How do markets perform between countries and regions?
4. What market segments are contributing to maximum share and greatest growth?
5. What is the product or procedure volumes by country and regions?

Actionable Insights Included:
1. Product portfolio matrix (Share vs. Growth)
2. Market attractiveness (Region vs. Growth)
3. Spot matrix (Product vs. Region)
4. Geographic distribution matrix (Share vs. Growth)

Cell Counting and Viability Analyzers Market

1. Product Type
1.1. Benchtop Analyzers
1.2. Automated High-Throughput Systems
1.3. Portable Handheld Analyzers

2. Technology
2.1. Electrical Impedance
2.2. Flow Cytometry
2.3. Image-Based Cytometry
2.4. Fluorescence-Based Detection

3. End User
3.1. Hospitals and Diagnostic Laboratories
3.2. Pharmaceutical and Biotechnology Companies
3.3. Academic and Research Institutions
3.4. Blood Banks
3.5. Contract Research Organizations

4. Geography
4.1. North America (U.S., Canada)
4.2. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
4.3. Asia Pacific (Japan, China, India, Rest of APAC)
4.4. Latin America (Brazil, Mexico, Rest of LA)
4.5. Rest of the World

5. Company Profiles
5.1. Thermo Fisher Scientific Inc.
5.2. Beckman Coulter, Inc.
5.3. Bio-Rad Laboratories, Inc.
5.4. Merck KGaA
5.5. ChemoMetec A/S
5.6. Sysmex Corporation
5.7. Horiba, Ltd.
5.8. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
5.9. DeNovix Inc.
5.10. Abbott Laboratories, Inc.

    Request Table of Contents / Sample Report

    Full Name*

    Company Email*

    Phone Number* [Please add country code]

    Subject*

    Message*

    Cell Counting and Viability Analyzers Market by Product Type (Benchtop Analyzers, Automated High-Throughput Systems and Portable Handheld Analyzers), Technology (Electrical Impedance, Flow Cytometry, Image-Based Cytometry and Fluorescence-Based Detection), and End User (Hospitals and Diagnostic Laboratories, Pharmaceutical and Biotechnology Companies, Academic and Research Institutions, Blood Banks and Contract Research Organizations) and Forecast 2034
    $3,000.00